Subscribe

The Contributions of Pharmaceutical Companies

AAHFN Clinical Perspectives
Pharmaceutical Companies’ Contributions
Videos — December 1, 2022
Johana Fajardo, DNP, ANP-C
MedStar Washington Hospital Center
Washington, DC
Johana Fajardo, DNP, ANP-C, discusses the contributions made by pharmaceutical companies that have evolved the amyloidosis treatment landscape.

Related Items

Words of Encouragement for Patients with Amyloidosis and Caregivers
By Natacha Baptiste, FNP-C; Johana Fajardo, DNP, ANP-C
Videos
AAHFN Clinical Perspectives
The Evolution of the Amyloidosis Treatment Landscape and the Hope It Brings to Patients
By Cindy Bither, RN, MSN, ANP-C, ACNP-C, CHFN
Videos
AAHFN Clinical Perspectives
A Feeling of Belonging: The Impact of Support Groups on Patients with Amyloidosis
By Cindy Bither, RN, MSN, ANP-C, ACNP-C, CHFN
Videos
AAHFN Clinical Perspectives
The Impact of Emerging Therapies on Patients with Amyloidosis
By Cindy Bither, RN, MSN, ANP-C, ACNP-C, CHFN
Videos
AAHFN Clinical Perspectives
Subscribe
Amyloidosis News
Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News by subscribing to receive the free AMN e‑Newsletter.

Sign Up for Amyloidosis News

Subscribe to receive the free, monthly AMN weekly e‑newsletter.

Subscribe

© Amplity Health. All Rights Reserved. Privacy Policy.